Drug Profile
Research programme: respiratory virus vaccine - Crucell/Vaxin
Alternative Names: Respiratory virus vaccine research programme - Crucell/VaxinLatest Information Update: 22 Jun 2011
Price :
$50
*
At a glance
- Originator Crucell; Vaxin
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory tract infections
Most Recent Events
- 22 Jun 2011 Discontinued - Preclinical for Respiratory tract infections in USA (unspecified route)
- 13 Sep 2004 Preclinical trials in Respiratory tract infections in USA (unspecified route)